RESUMEN
Ginger (Rhizoma zingiberis, RZ) has been used as a food, spice, supplement, flavoring agent, and as an edible herbal medicine. It is characterized by its pungency and aroma, and is rich in nutrients with remarkable pharmacological effects. It is used in traditional medicine clinics to treat diseases and symptoms, such as colds, headache, and primary dysmenorrhea (PD). In China, a variety of processed products of RZ are used as herbal medicines, such as baked ginger (BG) or ginger charcoal (GC) to treat different diseases and symptoms. However, the molecular mechanism of the therapeutic effect of RZ and its processed products (RZPPs, including BG or GC) against PD has not been well characterized. Moreover, whether the transient receptor potential (TRP) ion channels are involved in this process is not clear. In the present study, UHPLC-Q-TOF MS was adopted to analyse the differential quality markers (DQMs) between RZ and RZPPs. In addition, differential metabolomics (DMs) was acquired between RZ- and RZPPs-treated estradiol valerate coupled with an oxytocin-induced PD mouse uterus using untargeted metabolomics (UM). A correlation analysis between DQMs and DMs was also conducted. Benzenoids, lipids, and lipid-like molecules were the main DQMs between RZ and RZPPs. RZ and RZPPs were found to improve the pathological status of the uterus of a PD mouse, with significantly decreased serum levels of E2, PGF2α, TXB2 and remarkably increased levels of PROG and 6-keto-PGF1α. Moreover, RZ and RZPPs alleviated PD in mice via regulating the TRP ion channel-mediated ERK1/2/NF-κB signaling pathway. Our results indicate that the therapeutic effect of RZ and RZPPs against PD may be mediated by regulating the TRP ion channel-mediated ERK1/2/NF-κB signaling pathway, and provide a reference for the development of new dietary supplements or medicines.
Asunto(s)
Medicamentos Herbarios Chinos , Plantas Medicinales , Zingiber officinale , Humanos , Femenino , Ratones , Animales , Dismenorrea/tratamiento farmacológico , Dismenorrea/metabolismo , Oxitocina/metabolismo , Oxitocina/uso terapéutico , FN-kappa B/genética , FN-kappa B/metabolismo , Medicamentos Herbarios Chinos/farmacología , Estradiol , Transducción de Señal , Canales Iónicos/metabolismo , Canales Iónicos/uso terapéutico , Prostaglandinas F/uso terapéuticoRESUMEN
CONTEXT: The role of metabolic hormones, medicinal plants and their interrelationships in the control of human reproductive processes are poorly understood. AIMS: To examine how leptin, obestatin and ginkgo (Ginkgo biloba L.) affect human ovarian hormone release. METHODS: We analysed the influence of leptin and obestatin alone and in combination with ginkgo extract on cultured human ovarian granulosa cells. The release of progesterone (P), insulin-like growth factor I (IGF-I), oxytocin (OT) and prostaglandin F (PGF) were analysed by enzyme immunoassay and enzyme-linked immunosorbent assay. KEY RESULTS: Leptin addition promoted the release of all the measured hormones. Obestatin stimulated the release of P, IGF-I and OT and inhibited PGF output. Ginkgo suppressed P, IGF-I and OT and promoted PGF release. Furthermore, ginkgo changed the stimulatory action of leptin on PGF to an inhibitory one. CONCLUSIONS: Leptin and obestatin are involved in the control of human ovarian hormone release and ginkgo influences their function. IMPLICATIONS: Leptin and obestatin could be useful as stimulators of human ovarian cell functions. The suppressive influence of ginkgo on ovarian function should lead to the development of ginkgo-containing drugs.
Asunto(s)
Ghrelina , Ginkgo biloba , Células de la Granulosa , Leptina , Preparaciones de Plantas , Femenino , Humanos , Células Cultivadas , Ghrelina/farmacología , Ginkgo biloba/química , Células de la Granulosa/efectos de los fármacos , Células de la Granulosa/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Leptina/farmacología , Progesterona/metabolismo , Prostaglandinas F/metabolismo , Preparaciones de Plantas/farmacologíaRESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: Guizhi-Fuling capsule (GZFL), a well-known herbal remedy, has been widely used to treat primary dysmenorrhea (PD). Hence, systematic identifying multiple active ingredients and the involved mechanism is essential and urgently needed for GZFL. AIM OF THE STUDY: This study was planned to assess the pharmacokinetics of GZFL in rats, and identify whether these GZFL-derived absorbed components (ACs) contribute to the efficacy of source herbs and relevant mechanism. MATERIALS AND METHODS: The in vivo pharmacokinetic profile of 11 phytochemicals and 13 metabolites in healthy and PD rats were evaluated using liquid chromatography with mass spectrometry (LC-MS/MS). Whereafter, the introduced contribution strategy assessed ACs' effect (doses = their contents in GZFL) in PD rats with the mechanism. RESULT: The pharmacokinetic profiles of prototypes and metabolites differed in healthy and PD rats. As a main proxy of GZFL, 11ACs exerted an anti-PD effect (improvement of indexes for writhing latency, writhing time, PGF2α/PGE2, TXB2/6-keto-PGF1α and ß-EP) by regulating PI3K-Akt/ERK pathway. CONCLUSION: As a paradigmatic example, 11ACs contributed an average of 113.55% to GZFL in terms of anti-PD efficacy, providing an approach to rapidly, accurately and consistently identify the bioactive components and their pathway from herbs.
Asunto(s)
Medicamentos Herbarios Chinos , Fosfatidilinositol 3-Quinasas , Animales , Cromatografía Liquida , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Dismenorrea/tratamiento farmacológico , Femenino , Humanos , Prostaglandinas F , Proteínas Proto-Oncogénicas c-akt , Ratas , Espectrometría de Masas en Tándem/métodosRESUMEN
This study aims to explore the anti-inflammatory and hemostatic effects of the total extract of Clinopodium chinense(TEC), total saponins of C. chinense(TSC), and total flavonoids of C. chinense(TFC) in female rats with abnormal uterine bleeding(AUB), and the possible mechanism. Mifepristone(i.g., 12.4 mg·kg~(-1)) and misoprostol(i.g., 130 µg·kg~(-1)) were used to induce AUB in SD female rats conceiving on the same day. Then the AUB rats were randomized into model group, TEC group, TSC group, TFC group, Yimucao Granules(LG) group, and estradiol valerate(EV) group, with 8 rats in each group. Another 8 non-pregnant female rats were selected as normal group. During the experiment, each group was given the corresponding drug by gavage once a day for 7 days. After the administration, blood and uterine tissue were collected. The uterine bleeding volume was measured by ultraviolet spectrophotometry and the pathological changes of endometrium were observed based on hematoxylin-eosin(HE) staining. In addition, the microvessel density of endometrium was determined by immunohistochemistry, and the content of thromboxane B2(TXB2), 6-keto-PGF_(1α), interleukin-6(IL-6), and tumor necrosis factor-α(TNF-α) in plasma and levels of lutenizing hormone(LH), follicle stimulating hormone(FSH), estradiol(E_2), and progesterone in serum were detected by enzyme-linked immunosorbent assay(ELISA). The mRNA and protein expression of estrogenreceptor α(ERα), progesterone receptor(PR), matrix metalloproteinase(MMP)-2, MMP-9, and vascular endothelial growth factor(VEGF) in uterine tissue was determined by Western blot. Compared with the model group, TEC, TSC, and TFC can reduce uterine bleeding volume, alleviate the pathological damage of endometrium, and increase the microvessel density in endometrium. Moreover, TEC and TSC can significantly raise plasma TXB2 level and ratio of TXB2 to 6-keto-PGF_(1α), and TEC and TFC can significantly reduce the levels of IL-6 and TNF-α. In addition, TEC significantly elevated serum progesterone level and TFC significantly increased serum levels of E_2, FSH, and LH. TSC can significantly raise serum progesterone and FSH levels. In addition, TEC can significantly down-regulate the protein expression of PR, MMP-2, and VEGF and TSC significantly reduced the expression of MMP-9. TFC significantly decreased the expression of PR, MMP-9, and VEGF, and up-regulated the expression of ERα. In conclusion, TEC, TSC, and TFC all show therapeutic effects on AUB, particularly TEC. TSC exerts the effects by enhancing the coagulation function and promoting endometrial repair, and TFC by regulating estrogen levels and reducing inflammatory response. This study reveals the mechanism of C. chinense against AUB and also explains the holistic characteristics of Chinese medicine.
Asunto(s)
Hemostáticos , Lamiaceae , Saponinas , Animales , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Estradiol , Receptor alfa de Estrógeno , Femenino , Flavonoides/farmacología , Flavonoides/uso terapéutico , Hormona Folículo Estimulante/uso terapéutico , Humanos , Interleucina-6/genética , Metaloproteinasa 9 de la Matriz , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Progesterona , Prostaglandinas F/uso terapéutico , Ratas , Saponinas/farmacología , Saponinas/uso terapéutico , Factor de Necrosis Tumoral alfa , Hemorragia Uterina/tratamiento farmacológico , Hemorragia Uterina/patología , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
Worldwide demand for petroleum products has resulted in increased oil and gas activities in many countries. Conventional and unconventional oil and gas extraction, production, and transport lead to increased levels of petroleum-derived polycyclic aromatic hydrocarbons (PAHs) in the environment. PAH exposure has profound effects on reproduction by affecting pathways involved in placental trophoblast cell function and impairing normal placental development and function-key contributors to reproductive success. However, other components found in petroleum and wastewaters from oil and gas extraction, including the sulfur-containing heterocyclic aromatic compounds such as dibenzothiophene (DBT) and its alkylated derivatives, may also impact reproductive success. The goal of this study was to examine the effect of exposure to DBT, a compound commonly detected in the environment, and one of its alkylated analogues, 2,4,7-trimethyldibenzothiophene (2,4,7-DBT), on steroidogenic and angiogenic pathways critical for mammalian development in placental trophoblast cells (HTR-8/SVneo cells). 2,4,7-DBT but not DBT increased estradiol output in association with increased tube-like formation (surrogate for angiogenesis). These changes in angiogenesis did not appear to be related to altered expression of the key placental angiogenic gene targets (ANGPTL4, VEGFA, and PGF). Neither compound showed a concentration related effect on progesterone synthesis or its receptor expression. Our results suggest that 2,4,7-DBT can disrupt key pathways important for placental trophoblast function and highlight the importance of determining the impact of exposure to both parent and alkylated compounds. Further, these data suggest that exposure to sulfur-containing heterocyclic aromatic compounds may lead to placental dysfunction and impact reproductive success at environmentally relevant levels.
Asunto(s)
Placenta/efectos de los fármacos , Tiofenos/toxicidad , Trofoblastos/efectos de los fármacos , Alquilación , Proteína 4 Similar a la Angiopoyetina/efectos de los fármacos , Proteína 4 Similar a la Angiopoyetina/genética , Línea Celular , Disruptores Endocrinos/toxicidad , Estradiol/metabolismo , Femenino , Humanos , Industrias , Neovascularización Fisiológica/efectos de los fármacos , Petróleo , Embarazo , Prostaglandinas F/metabolismo , Tiofenos/química , Factor A de Crecimiento Endotelial Vascular/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/genéticaRESUMEN
The influence of environmental contaminant toluene and of plant fennel (Foeniculum vulgare Mill.) on reproduction are reported, but the mechanisms of their action and the protective effect of fennel on contaminant influence remain to be elucidated. In this study, we hypothesized that toluene and fennel directly affects basic ovarian cell functions, and that fennel can be used as an appropriate natural protective agent against the potential adverse effects of toluene. This study aimed to examine the action of toluene (20 µg/mL) and fennel extract (0, 1, 10, 100 µg/mL), and assess their combination on viability, proliferation, apoptosis, and hormone release by cultured healthy mare ovarian granulosa cells. Viability, proliferation (percentage of PCNA-positive cells), apoptosis and release of progesterone, oxytocin and prostaglandin F were evaluated by using Trypan blue exclusion tests, immunocytochemistry and enzyme immunoassays, respectively. Toluene, when given alone, inhibited viability, proliferation, apoptosis, progesterone, prostaglandin F and IGF-I. However, it did not affect oxytocin release. Moreover, Fennel, when given alone, inhibited viability, progesterone, and prostaglandin F release, as well as stimulating proliferation and oxytocin release. In addition, Fennel did not affect apoptosis. When given in combination with toluene, fennel was able to suppress, and even invert, the effects of toluene on viability, proliferation, apoptosis, prostaglandin F, and IGF-I. However, it did not alter its effect on progesterone release. Moreover, fennel induced the inhibitory effect of toluene on oxytocin output. The findings of our study suggest direct adverse effects of toluene on the basic ovarian functions of mares. Lastly, we also observed the direct influence of fennel on these functions, as well as its ability to be a natural protector against the action of toluene on the ovarian functions of mares.
Asunto(s)
Foeniculum/química , Células de la Granulosa/efectos de los fármacos , Tolueno/toxicidad , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Femenino , Caballos , Factor I del Crecimiento Similar a la Insulina/metabolismo , Oxitocina/farmacología , Extractos Vegetales/farmacología , Progesterona/farmacología , Prostaglandinas F/metabolismoRESUMEN
We examined the effects of metabolic hormones leptin and ghrelin, and the oil-related environmental contaminants toluene and xylene on the release of ovarian hormones by gravid and non-gravid cats, as well as the functional interrelationships between metabolic hormones and contaminants. Ovarian fragments of non-gravid cats were cultured with and without leptin and toluene. Next, ovarian fragments of either non-gravid or gravid animals were cultured with and without ghrelin and xylene. Oxytocin (OT) and prostaglandin F (PGF) release was measured using ELISA. We confirm ovarian OT and PGF production by feline ovary, demonstrate the involvement of leptin and ghrelin in controlling OT and PGF release, show the direct influence of toluene and xylene on feline ovarian secretory activity, indicate the ability of leptin and ghrelin to mimic and promote the main contaminant effects, demonstrate that oil-related contaminants can prevent and even invert the effects of leptin and ghrelin on the ovary, and suggest the gravidity-associated changes in ability of ghrelin to promote xylene action on PGF (but not to OT), but not in basic ovarian OT and PGF release and their response to ghrelin or xylene.
Asunto(s)
Ghrelina/farmacología , Leptina/farmacología , Ovario/efectos de los fármacos , Oxitocina/metabolismo , Prostaglandinas F/metabolismo , Tolueno/toxicidad , Animales , Gatos , Contaminantes Ambientales/toxicidad , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Ghrelina/administración & dosificación , Ghrelina/metabolismo , Humanos , Leptina/administración & dosificación , Leptina/metabolismo , Ovario/metabolismo , Oxitocina/genética , Petróleo/análisis , Embarazo , Xilenos/toxicidadRESUMEN
Zhi-Xiong Capsules (ZXC) involving Hirudo, Ligusticum chuanxiong, Salvia miltiorrhiza, Leonurus artemisia, and Pueraria lobata, is an empirical prescription used in Chinese clinics applied for treating cerebral arteriosclerosis and blood-stasis in clinic. However, the mechanism of its antithrombotic activity has not been investigated until now. The present study was designed to investigate its antithrombotic effects, the mechanism of ZXC on anti-thrombus action and to identify the main chemical composition of ZXC using HPLC-DAD-ESI-IT-TOF-MS. Two animal models were used to evaluate the antithrombotic effect of ZXC, the arterial thrombosis model and a venous thrombosis model. ZXC prolonged the plasma recalcification time (PRT), the activated partial thromboplastin time (APTT), the thrombin time (TT) and the prothrombin time (PT) and clearly reduced the content of fibrinogen (FIB) obviously in the arterial thrombosis model. Furthermore, it markedly suppressed the level of TXB2 and up-regulated the level of 6-keto-PGF1a. In addition, it significantly up-regulated the level of t-PA and down-regulated the level of PAI-1 (p < 0.05). These results revealed that ZXC played a vital role in the prevention of thrombosis through interacting with multiple targets, including inhibition of coagulation and platelet aggregation and increasing thrombolysis. A total of 23 compounds were identified as the main components of ZXC by HPLC-DAD-ESI-IT TOF-MS.
Asunto(s)
Antitrombinas/farmacología , Coagulación Sanguínea/efectos de los fármacos , Medicamentos Herbarios Chinos/uso terapéutico , Fibrinólisis/efectos de los fármacos , Activación Plaquetaria/efectos de los fármacos , Enfermedad Aguda , Animales , Anticoagulantes/farmacología , Anticoagulantes/uso terapéutico , Antitrombinas/uso terapéutico , Aspirina/farmacología , Cápsulas , Arterias Carótidas/efectos de los fármacos , Arterias Carótidas/patología , Cloruros , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Medicamentos Herbarios Chinos/farmacología , Compuestos Férricos , Heparina/farmacología , Pulmón/efectos de los fármacos , Pulmón/patología , Ratones , Agregación Plaquetaria/efectos de los fármacos , Prostaglandinas F/sangre , Prostaglandinas F/metabolismo , Embolia Pulmonar/sangre , Embolia Pulmonar/complicaciones , Embolia Pulmonar/tratamiento farmacológico , Conejos , Ratas Sprague-Dawley , Terapia Trombolítica , Trombosis/sangre , Trombosis/complicaciones , Trombosis/tratamiento farmacológico , Tromboxano B2/farmacologíaRESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: Panax quinquefolium saponin (PQS) is the active component extracted from traditional Chinese medicine Panax quinquefolius L. and has been widely used as a supplement to dual antiplatelet drugs (DA) for treatment of coronary artery disease (CAD) for two decades; however, the efficacy of PQS combined with DA against platelet adhesion to endothelial cells (ECs), an essential step in thrombosis, remains unclear. AIM OF THE STUDY: To compare PQS combined with DA and DA alone in inhibiting platelet adhesion to injured human umbilical vein endothelial cells (HUVECs) and to explore the possible mechanisms focusing on PI3K/AKT, COX-2/6-keto-PGF1α, and COX-1/TXB2 pathways. METHODS: HUVECs injured by oxidized low-density lipoprotein (ox-LDL) were randomly allocated into control, model, DA, PQS+DA (P+DA), LY294002 (a PI3K inhibitor)+DA (L+DA), and LY294002+PQS+DA (LP+DA) groups. HUVEC apoptosis, platelet adhesion to injured HUVECs, and platelet CD62p expression were assayed by fluorescence activated cell sorting (FACS). The concentrations of 6-keto-PGF1α and TXB2 in the supernatant were measured by radioimmunoassay. Protein expression of phosphorylated-PI3K, PI3K, phosphorylated-AKT, AKT, COX-1, and COX-2 in both platelets and HUVECs was evaluated by western blot. RESULTS: Compared to DA alone, PQS combined with DA reduced platelet adhesion to HUVECs and HUVEC apoptosis more potently, increased the concentration of supernatant 6-keto-PGF1α and up-regulated phospho-AKT protein in HUVECs. LY294002 mitigated the effects of PQS on HUVEC apoptosis and platelet adhesion. CONCLUSIONS: These findings show that PQS as a powerful supplement to DA, attenuated HUVEC apoptosis and improved the DA-mediated reduction of platelet adhesion to injured HUVECs and the underlying mechanisms may be associated with PI3K/AKT and COX pathways in HUVECs and platelets. PQS might provide a new complementary approach to improve the prognosis of thrombotic diseases in future.
Asunto(s)
Aspirina/farmacología , Plaquetas/efectos de los fármacos , Ciclooxigenasa 1/metabolismo , Ciclooxigenasa 2/metabolismo , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Fosfatidilinositol 3-Quinasa/metabolismo , Adhesividad Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/farmacología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Saponinas/farmacología , Ticlopidina/análogos & derivados , Apoptosis/efectos de los fármacos , Plaquetas/enzimología , Células Cultivadas , Cromonas/farmacología , Clopidogrel , Quimioterapia Combinada , Células Endoteliales de la Vena Umbilical Humana/enzimología , Células Endoteliales de la Vena Umbilical Humana/patología , Humanos , Lipoproteínas LDL/toxicidad , Morfolinas/farmacología , Selectina-P/metabolismo , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación , Fitoterapia , Plantas Medicinales , Inhibidores de Agregación Plaquetaria/aislamiento & purificación , Prostaglandinas F/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Saponinas/aislamiento & purificación , Transducción de Señal/efectos de los fármacos , Tromboxano B2/metabolismo , Ticlopidina/farmacologíaRESUMEN
BACKGROUND: Chronic airway inflammation is coordinated by a complex of inflammatory mediators, including eicosanoids. The aim of this study was to evaluate the impact of polycyclic aromatic hydrocarbons (PAHs) on the human lung epithelial carcinoma A549 cells supplemented with docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids. METHODS: We analyzed the influence of DHA, EPA and/or benzo(a)pyrene (BaP), chrysene (Chr), fluoranthene (Flu) and benzo(a)anthracene (Baa) treatment on the fatty acids (FAs) profile and the formation of isoprostanes. We studied the cyclooxygenase-2, FP-receptor, peroxisome proliferator-activated receptors PPARδ and PPARγ, transcription factor NF-кB p50 and p65 expression by Western blot, phospholipase A2 (cPLA2) activity, as well as aryl hydrocarbon receptor (AHR), cytochrome P450 (CYP1A1), phospholipase A2 (PLA2G4A) and prostaglandin synthase 2 (PTGS2) gene expression by qRT-PCR. RESULTS: DHA or EPA supplementation and BaP or Baa treatment resulted in a higher level of PGF3α. COX-2 expression was decreased while PPARδ expression and cPLA2 activity was increased after fatty acid supplementation and PAHs treatment. DHA and EPA up-regulated AHR and PLA2G4A genes. CONCLUSIONS: Supplementation with n-3 FAs resulted in changes of inflammatory-state related genes in the lung epithelial cells exposed to PAHs. The altered profile of lipid mediators from n-3 FA as well as repression of the COX-2 protein by n-3 PUFAs in A549 cells incubated with PAHs suggests anti-inflammatory and pro-resolving properties of DHA and EPA. It remains to be shown whether these pleiotropic and protective actions of n-3 FAs contribute to fish oil's therapeutic effect in asthma.
Asunto(s)
Células Epiteliales/efectos de los fármacos , Ácidos Grasos Omega-3/farmacología , Inflamación/genética , Pulmón/efectos de los fármacos , Hidrocarburos Policíclicos Aromáticos/farmacología , Células A549 , Benzo(a)pireno/farmacología , Línea Celular Tumoral , Crisenos/farmacología , Ciclooxigenasa 2/metabolismo , Citocromo P-450 CYP1A1/metabolismo , Ácidos Docosahexaenoicos/farmacología , Ácido Eicosapentaenoico/farmacología , Células Epiteliales/metabolismo , Fluorenos/farmacología , Expresión Génica/efectos de los fármacos , Fosfolipasas A2 Grupo IV/metabolismo , Humanos , Pulmón/metabolismo , FN-kappa B/metabolismo , PPAR gamma/metabolismo , Prostaglandinas F/metabolismo , Receptores de Hidrocarburo de Aril/metabolismoRESUMEN
BACKGROUND/OBJECTIVES: Effects of high-protein diets that are rich in saturated fats on cell adhesion molecules, thrombogenicity and other nonlipid markers of atherosclerosis in humans have not been firmly established. We aim to investigate the effects of high-protein Malaysian diets prepared separately with virgin olive oil (OO), palm olein (PO) and coconut oil (CO) on cell adhesion molecules, lipid inflammatory mediators and thromobogenicity indices in healthy adults. METHODS: A randomized cross-over intervention with three dietary sequences, using virgin OO, PO and CO as test fats, was carried out for 5 weeks on each group consisting of 45 men and women. These test fats were incorporated separately at two-thirds of 30% fat calories into high-protein Malaysian diets. RESULTS: For fasting and nonfasting blood samples, no significant differences were observed on the effects of the three test-fat diets on thrombaxane B2 (TXB2), TXB2/PGF1α ratios and soluble intracellular and vascular cell adhesion molecules. The OO diet induced significantly lower (P<0.05) plasma leukotriene B4 (LTB4) compared with the other two test diets, whereas PGF1α concentrations were significantly higher (P<0.05) at the end of the PO diet compared with the OO diet. CONCLUSION: Diets rich in saturated fatty acids from either PO or CO and high in monounsaturated oleic acid from virgin OO do not alter the thrombogenicity indices-cellular adhesion molecules, thromboxane B2 (TXB2) and TXB2/prostacyclin (PGF1α) ratios. However, the OO diet lowered plasma proinflammatory LTB4, whereas the PO diet raised the antiaggregatory plasma PGF1α in healthy Malaysian adults. This trial was registered at clinicaltrials.gov as NCT 00941837.
Asunto(s)
Arecaceae/química , Moléculas de Adhesión Celular/sangre , Dieta Alta en Grasa/efectos adversos , Grasas Insaturadas en la Dieta/efectos adversos , Aceite de Oliva/uso terapéutico , Trombosis/etiología , Trioleína/efectos adversos , Adulto , Algoritmos , Biomarcadores/sangre , Moléculas de Adhesión Celular/química , Aceite de Coco , Estudios Cruzados , Dieta Alta en Grasa/etnología , Grasas Insaturadas en la Dieta/normas , Grasas Insaturadas en la Dieta/uso terapéutico , Femenino , Humanos , Leucotrieno B4/sangre , Malasia/epidemiología , Masculino , Persona de Mediana Edad , Aceite de Oliva/normas , Aceites de Plantas/efectos adversos , Prostaglandinas F/sangre , Riesgo , Trombosis/epidemiología , Trombosis/etnología , Trombosis/prevención & control , Tromboxano B2/sangre , Adulto JovenRESUMEN
BACKGROUND: Soy-based intravenous fat emulsion (IVFE) is known to cause a rise in pulmonary artery pressure in the preterm infant, thought to be mediated through eicosanoid metabolites of linoleic acid. We compared the effect of soy-based IVFE and an olive-oil-based IVFE containing less than half the content of linoleic acid on pulmonary artery pressure and eicosanoid metabolites in preterm infants receiving parenteral nutrition. METHODS: In this pilot study at a regional neonatal intensive care unit (ICU), infants received either a soy-based or olive-oil-based IVFE as part of an otherwise identical feeding protocol. Pulmonary artery pressure and urinary thromboxane B2 and prostaglandin F1 alpha were measured at baseline and maximum lipid infusion. RESULTS: There was a greater fall in pulmonary artery pressure in the olive-oil-based IVFE group compared with the soy-based IVFE group. A decrease in urine thromboxane/prostaglandin F1 alpha ratio was seen only in the olive-oil-based IVFE group. CONCLUSIONS: In the parenterally fed preterm infant, an olive-oil-based IVFE may have a beneficial effect on pulmonary artery pressure when compared with soy-based IVFE. Effects on pulmonary vascular tone are likely to be mediated through alterations in eicosanoid metabolism. A randomized trial is warranted to compare the effects of different lipid emulsions.
Asunto(s)
Grasas de la Dieta/farmacología , Eicosanoides/orina , Emulsiones Grasas Intravenosas/farmacología , Recien Nacido Prematuro , Nutrición Parenteral , Aceites de Plantas/farmacología , Arteria Pulmonar/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Hemodinámica , Humanos , Lactante , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido , Ácido Linoleico/farmacología , Olea/química , Aceite de Oliva , Proyectos Piloto , Aceites de Plantas/química , Prostaglandinas F/sangre , Arteria Pulmonar/fisiología , Aceite de Soja/química , Aceite de Soja/farmacología , Glycine max/química , Tromboxano B2/orinaRESUMEN
The role of PGD2 has been recognized in allergy, innate immunity and inflammation. Western blot analysis identified 21 kDa lipocalin (L)-prostaglandin D2 (PGD2) synthase (S) in human osteoarthritis (OA)-affected cartilage, whose expression was increased by IL-1ß and TNFα. Similarly, PGD2 was spontaneously released by human OA-affected cartilage (and upregulated by IL-ß) in ex vivo conditions and could be inhibited by indomethacin. Addition of PGD2 to human OA-affected cartilage significantly increased accumulation of PGE2, PGF1α, PGF2α, TXB2, but inhibited LTB4 and nitric oxide (NO) accumulation. Similarly, PGD2 (but not 13,14-dihydro-15-keto PGD2) augmented IL-1ß induced PGE2 but inhibited IL-ß induced nitric oxide (NO) in human chondrocytes. Celecoxib (10 µM) inhibits COX-1 mediated PGD2, and nitric oxide synthase (NOS) mediated NO in human OA-affected cartilage. Furthermore, celecoxib (1 µM) counter balances (IL-1ß induced+PGD2 modulated) levels of NO and PGE2 in human OA-affected cartilage and chondrocytes to basal levels. These results show concentration-dependent, pro- and anti-inflammatory activity of PGD2 in human chondrocytes and cartilage, which can be neutralized by celecoxib. In view of the broad prostaglandin dependent and independent mechanism of action of celecoxib, these observations further reaffirm the broader role of celecoxib as a "Disease Modifying Drug" for human Osteoarthritis.
Asunto(s)
Condrocitos/efectos de los fármacos , Osteoartritis/metabolismo , Prostaglandina D2/metabolismo , Pirazoles/farmacología , Sulfonamidas/farmacología , Celecoxib , Células Cultivadas , Condrocitos/inmunología , Condrocitos/patología , Dinoprost/metabolismo , Dinoprostona/metabolismo , Humanos , Mediadores de Inflamación/metabolismo , Interleucina-1beta/inmunología , Rodilla/patología , Leucotrieno B4/metabolismo , Óxido Nítrico/metabolismo , Prostaglandina D2/inmunología , Prostaglandinas F/metabolismo , Tromboxano B2/metabolismoRESUMEN
Ischemia-reperfusion (IR) can lead to serious tissue oxidative injury in animals. ShuJinHuoXue tablet (SJHXT) is a Chinese Traditional Medicine which can relax the muscles and stimulate the blood circulation and has been used as a clinical medicine. In the present study, we investigated the effects of SJHXT pretreatment on oxidative injury using an animal model of acute limb IR. Results showed that SJHXT pre-treatment (200, 300 and 400 mg/kg/day) markedly reduced serum endothelin-1 (ET-1), thromboxane B2 (TXB2) levels and thromboxane B2/6-keto- prostaglandin F1α (TXB2/6-Keto-PGF(1α)), wet weight/dried weight (W/D) ratio, myeloperoxidase (MPO), creatine kinase (CK), lactate dehydrogenase (LDH) activities, and increased serum nitric oxide (NO), 6-Keto-PGF(1α) levels and NO/ET-1 ratio in the IR+SJHXT groups. In addition, the SJHXT pre-treatment (200, 300 and 400 mg/kg/day) markedly reduced skeletal muscle Ca²âº, malondialdehyde (MDA) levels, increased Naâº-Kâº-ATPase, Ca²âº-Mg²âº-ATPase, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities. Our results suggest that SJHXT pre-treatment may improve skeletal muscle blood vessel microcirculation, decrease skeletal muscle oxidative injury and enhance antioxidant enzymes activities in IR animals.
Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Músculo Esquelético/irrigación sanguínea , Músculo Esquelético/efectos de los fármacos , Daño por Reperfusión/tratamiento farmacológico , Animales , ATPasa de Ca(2+) y Mg(2+)/metabolismo , Catalasa/metabolismo , Creatina Quinasa/sangre , Endotelina-1/sangre , L-Lactato Deshidrogenasa/sangre , Malondialdehído/metabolismo , Músculo Esquelético/enzimología , Músculo Esquelético/patología , Óxido Nítrico/sangre , Peroxidasa/sangre , Fitoterapia , Prostaglandinas F/sangre , Conejos , Daño por Reperfusión/sangre , Daño por Reperfusión/enzimología , Daño por Reperfusión/patología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Superóxido Dismutasa/metabolismo , Comprimidos , Tromboxano B2/sangreRESUMEN
Hormonal changes involved in the farrowing process partly control the initiation of lactation. Inducing farrowing by injection of PG may alter the normal prepartum hormonal cascade. The aim of the study was to investigate the consequences of farrowing induction on colostrum yield and composition, as well as newborn piglet growth. Gilts were treated with 2 mg of alfaprostol on d 113 of gestation (induced farrowing, IF, n = 9) or were injected with 1 mL of a saline solution (natural farrowing, NF, n = 11). Colostrum production was estimated during 24 h, starting at the onset of parturition, based on piglet BW gains. Colostrum samples were collected during the 36 h after the onset of parturition. Blood samples were collected from sows as of d 112 of pregnancy until d 2 postpartum (d 0 being the day of parturition). Piglet blood samples were obtained at birth, on d 1, and on d 21. Litter size and litter weight at birth did not differ between groups (P > 0.10). Farrowing induction did not influence (P > 0.10) colostrum yield (3.96 ± 0.20 kg) or piglet BW gain during d 1 postpartum (116 ± 8 g). At the onset of farrowing (T0), lactose content in colostrum was greater in IF sows than in NF sows (P < 0.05), whereas colostrum ash and protein contents were less (P < 0.05) in IF sows. Concentrations of IgG in colostrum were similar in both groups of sows, whereas concentrations of IgA at T0 were less in IF than in NF sows (P < 0.01). Overall, endocrine changes in blood from d -2 until d 2 (cortisol, prolactin, progesterone, and estradiol-17ß) were not altered by farrowing induction (P > 0.10), but 1 h after the injection of alfaprostol, IF sows had greater circulating concentrations of prolactin (P < 0.01) and cortisol (P < 0.10) than NF sows. The greater concentration of lactose in colostrum from IF sows could be attributed to this transient increase in prolactin and cortisol. At birth, concentrations of white blood cells were less in piglets born from IF sows (P < 0.01). On d 1 and 21, piglets from IF sows had similar IgG concentrations in plasma to piglets from NF sows (P > 0.1). In conclusion, farrowing induction at 113 d of pregnancy induced transient hormonal changes in sows and alterations in colostrum composition, without significantly affecting colostrum yield. It also modified some hematological variables of piglets at birth.
Asunto(s)
Calostro/química , Trabajo de Parto Inducido/veterinaria , Paridad , Prolactina/metabolismo , Porcinos/fisiología , Animales , Animales Recién Nacidos , Femenino , Inmunoglobulina G/sangre , Lactosa/sangre , Oxitócicos/farmacología , Embarazo , Prolactina/sangre , Prostaglandinas F/farmacología , Porcinos/crecimiento & desarrolloRESUMEN
OBJECTIVE: Previously, we observed decreased histopathological severity of acute necrotizing pancreatitis (ANP) by parenteral nutrition with n-3 fatty acids. Thus, we now sequentially analyzed the impact of n-3 fatty acids on prostaglandin and leukotriene synthesis in ANP. METHODS: One hundred ninety-eight Sprague-Dawley rats (11 groups, n = 18) underwent intraductal glycodesoxycholat instillation and 6-hour cerulein infusion. Afterward, saline was infused in groups 2, 4, 6, 8, and 10, whereas groups 3, 5, 7, 9, and 11 received infusion rich in n-3 fatty acids (Omegaven, Fresenius Kabi, Bad Homburg, Germany). Animals were killed after 6 (group 1), 10 (groups 2 and 3), 14 (groups 4 and 5), 18 (groups 6 and 7), 22 (groups 8 and 9), and 26 hours (groups 10 and 11). The pancreas was histopathologically examined, and the pancreatic eicosanoid metabolism (prostaglandin E2, prostaglandin F1alpha [PGF1alpha], and leukotrienes) and lipid peroxidation (thiobarbituric acid-reactive substance, superoxide dismutase, and glutathione peroxidase) were analyzed. RESULTS: Between the 14th and 26th hours, histopathologic scores (edema, inflammation, bleeding, and necrosis) were reduced in the n-3 fatty acid group compared with the corresponding saline group. Pancreatic prostaglandin E2 and PGF1alpha were decreased between the 10th and 18th hour by n-3 fatty acids; PGF1alpha was reduced after 26 hours compared with the corresponding saline group. Lipid peroxidation was decreased by n-3 fatty acids after 14 hours (thiobarbituric acid-reactive substance); however, there was no difference concerning lipid peroxidation protective enzymes (glutathione peroxidase and superoxide dismutase). CONCLUSIONS: Parenteral therapy with n-3 fatty acids decreased histopathologic severity in ANP by early inhibition of prostaglandin (E2 and F1alpha) synthesis and reduction of lipid peroxidation.
Asunto(s)
Ácidos Grasos Omega-3/farmacología , Páncreas/efectos de los fármacos , Pancreatitis Aguda Necrotizante/prevención & control , Prostaglandinas/biosíntesis , Animales , Ceruletida , Dinoprostona/metabolismo , Ácidos Grasos Omega-3/administración & dosificación , Ácidos Grasos Omega-3/uso terapéutico , Glutatión Peroxidasa/metabolismo , Leucotrienos/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Páncreas/metabolismo , Páncreas/patología , Pancreatitis Aguda Necrotizante/inducido químicamente , Pancreatitis Aguda Necrotizante/metabolismo , Prostaglandinas F/metabolismo , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Factores de TiempoRESUMEN
Interleukin-1 (IL1) has been shown to be a potent stimulator of prostaglandin (PG) production in bovine endometrium. The aim of the present study was to determine the cell types in the endometrium (epithelial or stromal cells) responsible for the secretion of PGE2 and PGF2alpha in response to IL1A, and the intracellular mechanisms of IL1A action. Cultured bovine epithelial and stromal cells were exposed to IL1A or IL1B (0.006-3.0 nM) for 24 h. IL1A and IL1B dose-dependently stimulated PGE2 and PGF2alpha production in the stromal cells, but not in the epithelial cells. The stimulatory effect of IL1A (0.06-3.0 nM) on PG production was greater than that of IL1B. The stimulatory actions of IL1A on PG production was augmented by supplementing arachidonic acid (AA). When the stromal cells were incubated with IL1A and inhibitors of phospholipase (PL) C or PLA2 (1 microM; anthranilic acid), only PLA2 inhibitor completely stopped the stimulatory action of IL1A on PG production. Moreover, a specific cyclooxygenase-2 (COX2) inhibitor blocked the stimulatory effect of IL1A on PG production. IL1A (0.06 nM) promoted COX2 and microsomal PGE synthase-1 (PGES1) gene and its protein expression. The expression of COX1, PGES2, PGES3, and PGF synthase (PGFS) mRNA was not affected by IL1A in the stromal cells. The overall results indicate that 1) the target of IL1A and IL1B for stimulating both PGE2 and PGF2alpha production is the stromal cells, 2) IL1A is a far more potent stimulator than IL1B on PG production in stromal cells, 3) the stimulatory effect of IL1A on PG production is mediated via the activation of PLA2 and COX2, and (4) IL1A induced PG production by increasing expressions of COX2 and PGES1 mRNAs and their proteins in bovine stromal cells.
Asunto(s)
Endometrio/citología , Interleucina-1/farmacología , Prostaglandinas/biosíntesis , Animales , Western Blotting , Bovinos , Células Cultivadas , Ciclooxigenasa 2/metabolismo , Endometrio/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Femenino , Hidroxiprostaglandina Deshidrogenasas/metabolismo , Interleucina-1alfa/farmacología , Oxidorreductasas Intramoleculares/metabolismo , Queratinas/metabolismo , Reacción en Cadena de la Polimerasa , Prostaglandina-E Sintasas , Prostaglandinas E/metabolismo , Prostaglandinas F/metabolismo , Células del Estroma/efectos de los fármacos , Células del Estroma/metabolismo , Vimentina/metabolismoRESUMEN
In vitro isometric myograph and histopathological studies were performed on rat middle cerebral arteries (MCAs) to explore changes in contractile capacity following experimental Gamma Knife radiosurgery. Right MCAs were treated with 25 Gy and 50 Gy at the 50% isodose line, while contralateral vessels received 15 Gy and 20 Gy at the 20% isodose region. Survival period varied from 3 to 18 months. Reduction in contractile capacity of irradiated normal rat MCAs was detected but their lumina remained patent. In another study, we investigated human AVM tissue cultures in order to detect genetic and phenotypic modifications contributing to vessel occlusion after irradiation. In culture, the proliferation index decreased considerably following 15-, 20-, 25- or 50-Gy irradiation at the 5th posttreatment day and remained depressed during the observation period of 14 days. P53, p21Waf-1 and mdm-2 mRNA contents were elevated significantly after irradiation, indicating enhanced apoptosis. Immunohistochemistry revealed vigorous vimentin positivity in the nonirradiated control AVM cultures, which gradually decreased by the time in the irradiated specimens. Smooth muscle alpha-actin positivity was prominent in the irradiated cultivated samples, suggesting transformation of resting fibroblasts onto activated myofibroblastic elements with contractile capacity. This transformation process was confirmed by the appearance of TGF-Beta in the irradiated AVM cell lines also. These data support the hypothesis that one of the contributing factors to AVM shrinkage and obliteration after radiosurgery might be fibrocyte-myofibroblastic cell transformation in the vessel wall.
Asunto(s)
Malformaciones Arteriovenosas Intracraneales/patología , Malformaciones Arteriovenosas Intracraneales/fisiopatología , Malformaciones Arteriovenosas Intracraneales/cirugía , Arteria Cerebral Media/patología , Arteria Cerebral Media/fisiología , Animales , Humanos , Arteria Cerebral Media/efectos de los fármacos , Arteria Cerebral Media/efectos de la radiación , Modelos Animales , Necrosis , Cloruro de Potasio/farmacología , Prostaglandinas F/farmacología , Radiocirugia/métodos , Ratas , Ratas Wistar , Técnicas de Cultivo de Tejidos , Uridina Trifosfato/farmacologíaRESUMEN
Linoleic acid (LA, 18:2n-6) has variously been found to increase or inhibit synthesis of 2-series prostaglandins (PGs), derived from arachidonic acid (AA, 20:4n-6). gamma-linolenic acid (GLA, 18:3n-6) containing oils are promoted to women for a variety of reproductive problems. Little is known concerning their actual effects on reproduction. We investigated the effects of LA, GLA and AA supplementation (25-100 microM) on basal and oxytocin (OT) stimulated production of 1-, 2- and-3 series PGs by uterine epithelial cells isolated from non-pregnant ewes, used as a model system to study endometrial PG production. PGF isomers were measured using radioimmunoassays following separation by high performance chromatography (HPLC). OT challenge increased the proportion of PGF2alpha in relation to PGF1alpha and PGF3alpha in control medium. LA supplementation decreased all PGF isomer production and reduced responsiveness to OT. GLA increased both absolute and proportional PGF1alpha production and slightly enhanced PGF2alpha generation. AA increased PGF2alpha generation and raised its isometric proportion. Both GLA and AA increased overall PGF output significantly but prevented the cells from responding to OT. These results suggest that consumption of LA and GLA are likely to differentially alter both uterine PG metabolism and responsiveness to OT. This may have implications for the control of a variety of reproductive processes.
Asunto(s)
Suplementos Dietéticos , Endometrio/citología , Células Epiteliales/metabolismo , Ácidos Grasos Omega-6/administración & dosificación , Prostaglandinas F/metabolismo , Útero/anatomía & histología , Animales , Ácido Araquidónico/administración & dosificación , Ácido Araquidónico/química , Ácido Araquidónico/metabolismo , Células Cultivadas , Células Epiteliales/citología , Ácidos Grasos Omega-6/química , Ácidos Grasos Omega-6/metabolismo , Femenino , Humanos , Ácido Linoleico/administración & dosificación , Ácido Linoleico/química , Ácido Linoleico/metabolismo , Oxitocina/metabolismo , Embarazo , Prostaglandinas F/química , Radioinmunoensayo , Ovinos , Ácido alfa-Linolénico/administración & dosificación , Ácido alfa-Linolénico/química , Ácido alfa-Linolénico/metabolismoRESUMEN
To find new prostanoid FP-receptor agonists possessing potent ocular-hypotensive effects with minimal side effects, we evaluated the agonistic activities of newly synthesized prostaglandin F(2alpha) derivatives for the prostanoid FP-receptor both in vitro and in vivo. The iris constrictions induced by the derivatives and their effects on melanin content were examined using cat isolated iris sphincters and cultured B16 melanoma cells, respectively. The effects of derivative ester forms on miosis and intraocular pressure (IOP) were evaluated in cats and cynomolgus monkeys, respectively. Of these derivatives, 6 out of 12 compounds were more potent iris constrictors, with EC(50) values of 0.6 to 9.4 nM, than a carboxylic acid of latanoprost (EC(50)=13.6 nM). A carboxylic acid of latanoprost (100 microM) significantly increased the melanin content of cultured B16 melanoma cells, but some 15,15-difluoro derivatives, such as AFP-157 and AFP-172, did not. Topically applied AFP-168, AFP-169 and AFP-175 (isopropyl ester, methyl ester and ethyl ester forms, respectively, of AFP-172) induced miosis in cats more potently than latanoprost. AFP-168 (0.0005%) reduced IOP to the same extent as 0.005% latanoprost (for at least 8 h). These findings indicate that 15,15-difluoroprostaglandin F(2alpha) derivatives, especially AFP-168, have more potent prostanoid FP-receptor agonistic activities than latanoprost. Hence, AFP-168 may be worthy of further evaluation as an ocular-hypotensive agent.